Should I Buy BSAC? BSAC 2026 Analysis

Should You Buy Banco Santander Chile (BSAC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

36.740

1 Day change

1.69%

52 Week Range

37.720

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient investor: price (~37.12 pre-market) is pressing into near-term resistance (R1 ~37.41) with RSI ~67.9 (close to overbought).
Wall Street price targets (around $28–$29) sit well below the current price, implying limited upside and elevated downside risk despite the bullish chart.
Options positioning is extremely call-skewed (OI put/call 0.02) but with essentially no volume today, which weakens the signal.
Net: bullish trend, but entry is unattractive at this level; better treated as a hold/avoid-new-buys until either a pullback toward support (~35.6 pivot) or a clean breakout above ~37.4–38.5 with follow-through.

Technical Analysis

Trend: Bullish structure with moving averages aligned upward (SMA_5 > SMA_20 > SMA_200), indicating an ongoing uptrend.
Momentum: MACD histogram +0.139 and expanding → bullish momentum still building.
Overbought risk: RSI_6 ~67.94 (upper-neutral, nearing overbought) → upside may be limited near-term.
Levels: Pivot ~35.61 (first key support), S1 ~33.81; Resistance at R1 ~37.41 then R2 ~38.52.
Pattern-based odds: Similar-pattern stats point to modest near-day/week gains but a negative 1-month bias (-2.69%), suggesting the current push may fade after a short-term pop.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning: Open interest is heavily call-dominant (call OI 129 vs put OI 2; OI put/call 0.02) → bullish/optimistic skew.
Activity: Today’s option volume is 0 (calls 0, puts 0) → sentiment read is mostly from legacy positioning, not fresh buying.
Volatility: Implied vol (30d) ~67.31 vs historical vol ~20.11 → options are priced rich vs realized movement; however IV percentile ~15.2 and IV rank ~10.75 suggest IV is low relative to its own history recently (IV has been higher in the past few days: 5d avg ~80.75).

Technical Summary

Sell

Buy

Positive Catalysts

supports a fundamentally resilient narrative.

Neutral/Negative Catalysts

and multiple Neutral ratings conflict with the current price (~37), implying the market may be ahead of consensus fundamentals.

Financial Performance

Latest quarter provided: 2025/Q3.
Growth trend: Revenue -1.73% YoY and net income -1.25% YoY → mild contraction, not accelerating growth.
EPS line shown as flat (0.00% YoY in the snapshot), offering no clear improvement signal from the provided quarterly data.
FY2025 headline update (news): Strong profitability (non-GAAP EPS $2.48) and solid capital ratios, but the quarterly trend in the snapshot is slightly down YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent direction: Multiple firms maintained Neutral while nudging price targets up (UBS to $29 from $24; Goldman to $28 from $25), indicating slightly improved expectations but not enough to turn bullish.
Key change: Citi downgraded from Buy to Neutral (PT raised to CLP 70 from CLP 65) citing moderating earnings growth and net interest margin recovery largely completed.
Wall Street pros: Modestly improving targets and stable outlook; not signaling distress.
Wall Street cons: Broad Neutral stance plus targets far below the current trading price suggests limited upside from here and supports a hold/avoid-new-buy stance at ~37.

3 Analyst Rating

Wall Street analysts forecast BSAC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BSAC is 29 USD with a low forecast of 28 USD and a high forecast of 30 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

3 Hold

0 Sell

Hold

Current: 36.130

Low

Averages

High

Current: 36.130

Low

Averages

High

UBS

Neutral

maintain

$24 -> $29

AI Analysis

2025-11-10

Reason

UBS

Price Target

$24 -> $29

AI Analysis

2025-11-10

maintain

Neutral

Reason

UBS raised the firm's price target on Santander Chile to $29 from $24 and keeps a Neutral rating on the shares.

Goldman Sachs

Tito Labarta

Neutral

maintain

$25 -> $28

2025-11-06

Reason

Goldman Sachs

Tito Labarta

Price Target

$25 -> $28

2025-11-06

maintain

Neutral

Reason

Goldman Sachs analyst Tito Labarta raised the firm's price target on Santander Chile to $28 from $25 and keeps a Neutral rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BSAC

Unlock Now

BSAC Should I Buy

BSAC Should I Buy

Should You Buy Banco Santander Chile (BSAC) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch